Indmark Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 276.23%
- Profit Growth 940.21%
- Ebitda 157.45%
- Net Worth 7.60%
- Total Assets -18.33%
About Indmark Biotech
Indmark Biotech Private Limited (IBPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 September 2021 (Three years and four months 29 days old ). Its registered office is in Yamuna Nagar, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Naresh Kumar and Mandeep Singh serve as directors at the Company.
Company Details
-
Location
Yamuna Nagar, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290HR2021PTC097637
-
Company No.
097637
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Sep 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Indmark Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Kumar
|
Director | 13-Sep-2021 | Current |
|
Mandeep Singh
|
Director | 13-Sep-2021 | Current |
Financial Performance of Indmark Biotech.
Indmark Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 276.23% increase. The company also saw a substantial improvement in profitability, with a 940.21% increase in profit. The company's net worth moved up by a moderate rise of 7.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indmark Biotech?
In 2023, Indmark Biotech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Alenrise Retail Private LimitedMandeep Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indmark Biotech?
Indmark Biotech has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indmark Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indmark Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
